MEDICONSEMedico Remedies Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 27 Jan, 2026 · 11:52 IST

Medico Remedies secures Rs 37.18 cr drug supply order from UP govt

Govt Defence OrderBusiness Updates View source PDFExplain this filing

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹51.52
prior close
₹51.39
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.0% vs market
Pharmaceuticals peers, median of 154sector-0.4%+0.5% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.2
15m
+0.7
30m
+1.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2+0.1+0.0-0.4+0.5
Next day
-5.0+2.2-7.1+0.1-5.1
2d
-4.6+1.8-6.4-0.7-3.9
3d
-2.5+3.6-6.1+0.0-2.5
4d
-7.8+2.3-10.1-0.0-7.8
5d
-4.6+6.1-10.7+2.4-7.0
1w
-6.5+6.4-13.0+1.9-8.5
15d
-8.1+7.0-15.1+1.9-10.0
1m
-13.4+3.8-17.2+0.7-14.1
2m
-36.7-5.2-31.5-8.0-28.7
3m
-19.6+12.5-32.0+4.3-23.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medico Remedies has secured a government supply order worth about Rs 37.18 crore from Uttar Pradesh Medical Supplies Corporation Limited, a Government of UP entity, to supply multiple drugs. The company must complete the full supply by 31 October 2026. This is a domestic order and promoters have no interest in the awarding entity.

Likely market impact

Positive: sizeable government order strengthens revenue visibility through FY27. No related party concerns.